Zanzalintinib
ZANACC
Exelixis · Phase 2 · Not yet recruiting · Enrollment 51
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
Zanzalintinib
Exelixis · Phase 2 · Not yet recruiting · Enrollment 51
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.